| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $28.3M | +15.8% |
| Cost of Revenue | $12.0M | -7.5% |
| Gross Profit | $16.3M | +42.5% |
| R&D Expense | $2.6M | +39.7% |
| SG&A Expense | $11.1M | +36.7% |
| Operating Income | $2.6M | +78.4% |
| Pre-tax Income | $2.5M | -9.3% |
| Income Tax | $572K | +132.3% |
| Net Income | $2.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.5M | -31.6% |
| Accounts Receivable | $3.0M | -22.9% |
| Inventory | $9.6M | +91.3% |
| Current Assets | $34.1M | +1.8% |
| Total Assets | $53.8M | +8.6% |
| Current Liabilities | $9.8M | +29.0% |
| Total Liabilities | $20.1M | +9.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.7M | -2041.9% |
| Capital Expenditures | $3.2M | -6.6% |
| Investing Cash Flow | -$3.3M | +10.6% |
| Financing Cash Flow | -$190K | -101.1% |
| Free Cash Flow | -$5.9M | -65.5% |
| -23.0% |
| EPS (Basic) | $0.18 | -28.0% |
| EPS (Diluted) | $0.18 | -28.0% |
| Stockholders' Equity |
| $33.7M |
| +7.9% |